Creditor Loses Bid For Nearly $4M Of BioChemics-SEC Deal

A Florida private equity firm cannot take priority over the U.S. Securities and Exchange Commission to recover nearly $4 million it was owed by a cash-strapped company being turned over to...

Already a subscriber? Click here to view full article